Skip to content

Addiction: all studies

Page 292 of 857: studies 2,911 to 2,920 of 8,563, newest first. Back to the addiction overview

Research

Neurological disorders caused by recreational use of nitrous oxide—a retrospective study from a German metropolitan area and review of the literature

Neurological Research and Practice May 4, 2025 Asya Tshagharyan, Se-Jong You, Christian Grefkes et al.

The recreational use of nitrous oxide (N2O) has seen a worldwide rise in the recent years, resulting in an increased incidence of neurological complications due to N2O-induced functional vitamin B12 deficiency. Here, we report on a cohort of patients admitted to a tertiary care center with neurological symptoms in the context of recreational N2O use between 2020 and 2024. We screened the...

1183 A Randomized, Double-blind, Placebo-Controlled Trial of Doxazosin for Nightmares and Sleep Disturbance in PTSD

Sleep May 1, 2025 Anne Richards, Leslie Yack, Anthony Santistevan et al.

Nightmares and non-nightmare sleep disturbances are a core feature of posttraumatic stress disorder. Effective treatments remain elusive. Doxazosin is an alpha-1 adrenergic blocker with demonstrated promise, but there is a dearth of evidence from randomized controlled trials on its effectiveness. We report findings from a randomized, double-blind, placebo-controlled trial evaluating the...

Identifying EEG markers related to acute cannabis consumption: A systematic review.

Neuroscience & Biobehavioral Reviews May 1, 2025 C Schiemer, Mathew J Summers, Kayla B Stefanidis 2 citations

Electroencephalography (EEG) has potential to provide a sensitive measure of the acute neurophysiological response to cannabis administration. As delta-9-tetrahydrocannabinol (THC; the psychoactive constituent of cannabis) can induce transient neurocognitive impairments that differ as a function of tolerance and dose, understanding the neural profile related to intoxication would be of great...

Psychedelics in Palliative Care

May 1, 2025 2 citations

Abstract This is the first book to explore the use of psychedelic medicines in palliative care and addiction medicine. Bringing together a diverse team of palliative physicians, therapists, researchers, spiritual guides, and entrepreneurs, the book explores the history, cultural significance, science, and legal status of eight major psychedelic medications. Each medication holds fascinating...

A Comprehensive Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Misuse

May 1, 2025 Eve E. Keighley, Dalia A Bedewy, Eid Abo Hamza et al. 1 citation preprint

Given the recent resurgence of using psychedelic drugs to treat substance misuse (SM), reviewing the latest information on their current status is essential. Substance use disorders (SUD) are psychiatric conditions that comprise the repetitive use of illicit substances, despite the harmful and damaging ramifications. Current treatment options for SUD are limited and have displayed low...

DOI: 10.31234/osf.io/mjhwf_v1 (opens in new tab) Meta-analysis Substance misuse Drug Psychoactive substance +1

Psilocybin

May 1, 2025 Jessi Humphreys, Lou Lukas, Yvan Beaussant et al.

Abstract Psilocybin, a naturally occurring psychoactive compound found in more than 200 mushroom species, has an enduring history of use in sacred rituals of Indigenous healers worldwide. With selective serotonin receptor binding, activation of the serotonergic neurological system enables psilocybin to potentiate neuroplasticity, enabling individuals to engage in meaning-making from psychedelic...

"I am not pain, I have pain": A pilot study examining iRest yoga nidra as a mind-body intervention for persistent pain.

Complementary Therapies in Clinical Practice May 1, 2025 Meg Barber, Subhadra Evans, Rosie Marks et al. 3 citations

This pilot study was the first of its kind to examine the experiences of people with persistent pain engaging in a six-week iRest for Pain group program as part of multidisciplinary pain care. The present study used a qualitative, phenomenological design and reflexive thematic analysis to gain an understanding of the firsthand experience of patients who participated in the iRest for Pain group...

DOI: 10.1016/j.ctcp.2025.101955 (opens in new tab) Full text (opens in new tab) Lived experience Meditation and pain Pilot trial Trauma and pain +1

Effectiveness of brief mindfulness training for athletes' mood: The moderating effect of burnout.

Acta Psychologica May 1, 2025 Fengbo Liu, Qingyang Yu, Shichang Cai et al. 2 citations

To explore the impact of brief mindfulness training on athletes' mood and the moderating effect of burnout between them. This study has employed the mixed experimental design of 2 (experimental conditions) × 2 (time points), randomly assigned 60 athletes into a mindfulness training group and a control group (30 athletes in each group), and selected the Five Facets Mindfulness Questionnaire...

DOI: 10.1016/j.actpsy.2025.104960 (opens in new tab) Full text (opens in new tab) Athlete Brief mindfulness Burnout Moderating effect +1

A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse.

Neuropsychopharmacology May 1, 2025 Marcus W. Meinhardt, Ivan Skorodumov, Jérôme Jeanblanc et al. 8 citations

The drug development process in psychiatry faces significant challenges due to low reproducibility rates in animal testing, which often leads to translation failures. To address this issue, we introduce a new approach in psychiatric drug development: a preclinical randomized controlled trial (preRCT). To demonstrate its potential utility, we conducted a multi-center preRCT using the alcohol...

DOI: 10.1038/s41386-025-02071-w (opens in new tab) Full text (opens in new tab) Addiction treatment Ketamine therapy Alcohol dependence Gender medicine +1